FEATURED IN PRODUCT ANNOUNCEMENTS
- Panasonic Upgrades Toughbook® H2 Rugged Handheld Tablet PC
- Physio-Control Introduces TrueCPR Coaching Device to Optimize Manual CPR Performance
- Cool Offs are Popular Product in Allegro Industries’ Comprehensive Cooling Line
- New Delta Rota-Beam™ Series Super-LED® Rotating Lightbar
- Allied Specialty Vehicles, Inc. Acquires Ambulance Manufacturer SJC Industries Orlando, Florida
- AdvanceDispatch Adds Real-Time Traffic Intelligence
- ZOLL AND REFLECTANCE MEDICAL FORM DEVELOPMENT AGREEMENT TO INCORPORATE MOBILE CAREGUIDE SENSOR INTO ZOLL MONITOR/DEFIBRILLATORS
Draeger Medical, Inc. is introducing new single-patient use ECG leads that help reduce the risk of nosocomial infections that are on the rise in hospital environments. The high-quality disposable leads support hospital guidelines for hygiene and help reduce the cost of care related to hospital acquired infections.
Available as 3- and 5-lead standard color coded sets, the single-patient use leads are fully shielded and provide signal quality equal to reusable leads. Complementing the existing portfolio of reusable leads, the single-patient use leads have been extensively tested and certified for use with the Dräger Infinity patient monitoring product range.
Several studies[i] have shown that ECG leads can be a pathway for antibiotic-resistant pathogens and a cause of healthcare associated infections. Furthermore, studies indicate that even after disinfection, over 77 percent of reusable leads are contaminated with at least one resistant pathogen. In addition to the significant increase in morbidity and mortality these infections can cause, hospital-acquired infections also increase the cost of care.
Their treatment can give rise to more resistant strains of microbes.
“Dräger developed the single-patient ECG leads to provide a solution to help reduce the risk of nosocomial infections in today’s hospital environment,” said Nuala Thomason, regional director of marketing, for Draeger Medical, Inc. “These infections have been shown to increase the average length of hospital stay by 9.5 days and increase treatment costs by more than $15,000.”
The single-patient use ECG leads are easily applied and eliminate the need for time-consuming preparation. The flexible ribbon cable also provides more comfort for patients and caregivers. The flexible cables also have a unique ability to adapt to patient size.
The Dräger single-patient use ECG lead system is manufactured by Dräger Medical GmbH.
Dräger. Technology for Life®
Dräger is a leading international company in the fields of medical and safety technology. Dräger products protect, support and save lives. Founded in 1889, in 2010 Dräger generated revenues of around EUR 2.18 billion. The Dräger Group is currently present in more than 190 countries and has about 11,000 employees worldwide. Please visit www.draeger.com for more information.
